ycobacterium senegalense is a rapidly growing Mycobacterium species, and has been reported to cause disease among cattle in east Africa (1). Rare human cases have been reported, but only in adults who were immunosuppressed and had other underlying medical conditions (2-4). We report an otherwise healthy child who developed an M senegalense soft tissue infection after suffering trauma from the shattered glass of a fish tank.
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Case presentation
A healthy three-year-old girl with no previous history of serious illness or hospitalizations presented to a local urgent care centre with multiple facial lacerations. While playing, she had pulled a fish tank containing several live freshwater fish, as well as multiple plastic plants and ceramic ornaments, down from a shelf. The fish tank glass had shattered causing three lacerations on her left cheek. The wounds were cleaned, and a combination of sutures and steri-strips were used to close them. No antibiotics were prescribed.
Two weeks after the injury, the lacerations had not healed and appeared indurated, reddened and thickened with elevated ridges. She was referred to a plastic surgeon, and all three scars were revised. Excision revealed prominent exudative material and granulation tissue under pressure. Swabs were sent for microbiological testing, but not for histopathology or cytopathology. No antibiotics were administered at that time.
The laboratory reported that acid-fast bacilli were observed in the direct specimen smear using fluorescent auramine rhodamine stain. After three days of incubation, growth was detected using the BD BACTEC 960 automated system (BD Diagnostic Systems, USA). An acid-fast organism was visualized growing in the BACTEC MGIT medium (BD Diagnostic Systems) using Ziehl-Neelsen stain. Initial appearance of the organism on subculture was a smooth, nonpigmented, rapidly growing acid-fast organism, which grew optimally at 37°C (range 25°C to 42°C, with rougher morphology appearing at lower temperatures). The organism was found to be positive for threeday arylsulfatase, nitrate, growth on MacConkey without crystal violet, iron uptake, and fructose and mannitol use. The isolate did not use arabinose or inositol. Based on these microbiological results, the isolate was sent to the National Reference Centre for Mycobacteriology, National Microbiology Laboratory (Winnipeg, Manitoba) for sequence-based species identification.
Sequencing of the 16S ribosomal RNA gene was performed using the following methodology. Crude DNA was extracted using a previously described method (5) . Briefly, the tubes containing the culture, buffer and silicon beads were boiled for 10 min and sonicated for 15 min at 35 kHz. The lysis tubes were then spun at 12,000 rpm for 2 min. All 16S ribosomal RNA polymerase chain reactions were performed using a previously described method (6) . The sequencing was performed on the ABI 3730XL sequencer (Applied Biosystems, USA) using a combination of universal primers to sequence the gene. The sequences were edited using Seqman Pro version 8.1.2 (DNASTAR Inc, USA), and analyzed using BioNumerics version 4.5 (Applied Maths Inc, USA). Sequences obtained were compared with a qualitycontrolled sequence database of Mycobacterium type strains and other published strains in the Genbank database (National Institutes of Health, USA) (6) . Using a combination of 16S gene sequencing and biochemical testing results (Table 1) , the patient's isolate was identified as M senegalense (3, 6) .
Susceptibility testing was performed by E-test using the minimum inhibitory concentration (MIC) breakpoints from the Clinical and Laboratory Standards Institute guidelines for the Mycobacterium fortuitum complex because no established guidelines are available specifically for M senegalense (7) . In vitro, the organism was susceptible to amikacin (MIC 0.5 µg/mL), clarithromycin (MIC 0.5 µg/mL), ciprofloxacin (MIC 0.25 µg/mL), doxycycline (MIC 0.25 µg/mL), cefoxitin (MIC 8 µg/mL), imipenem (MIC 2 µg/mL) and trimethoprim/ sulfamethoxazole (MIC 0.5/8.5 µg/mL), which are consistent with previously published results (3, 8) .
The child was referred to a pediatric infectious disease consultant once the microbiology results were reported. At that time, discharge The present report describes the first known case of an otherwise healthy child who developed a soft tissue infection due to Mycobacterium senegalense -a pathogen usually found in east Africa that is responsible for infecting various animals. The patient presented with nonhealing wounds after sustaining facial lacerations from the shattered glass of a fish tank. The patient responded well to scar revision and antibiotics, with no subsequent relapse. 
persisted from the most inferior scar, however, with minimal erythema and without evidence of regional lymphadenopathy or systemic symptoms such as fever. The patient was started on a combination of clarithromycin, trimethoprim/sulfamethoxazole and ciprofloxacin.
One month after the initiation of therapy, the drainage had stopped. All lesions were closed and well healed by three months, and treatment was discontinued. On subsequent follow-up at two months post-treatment, there was no evidence of relapse.
DisCUssion
The present case represents the first known M senegalense-associated infection in an immunologically normal pediatric host. The majority of soft tissue infections in children are caused by Streptococcus pyogenes or Staphylococcus aureus, although in this setting -injury from a fish tank source -Mycobacterium marinum has previously been reported (9) .
M senegalense has classically been associated with bovine farcy in east and central Africa, affecting zebu cattle in Chad, Nigeria, Senegal, Somalia and Sudan (1). Since it was first described in 1973 by Chamoiseau (14) , M senegalense has rarely been reported. This is most likely due to the placement of M senegalense in the M fortuitum complex (M fortuitum, Mycobacterium peregrinum, Mycobacterium mucogenicum, Mycobacterium mageritense, Mycobacterium farcinogenes, Mycobacterium septicum and the recently described members of the third biovariant Mycobacterium porcinum, Mycobacterium boenickei, Mycobacterium neworleansense, Mycobacterium houstonenense, Mycobacterium conceptionense and Mycobacterium brisbanense) (2). Also, the M senegalense 16S ribosomal RNA sequence is nearly identical to that of M farcinogenes, making identification of M senegalense difficult using this method. Others have shown M senegalense to be a separate, distinct species owing to individual 16S-23S ribosomal DNA internal transcribed spacer sequences (1), and it has been differentiated from M farcinogenes based on its biochemical activity, growth rate and DNA homology (2). In 2005, it was reported that Mycobacterium peregrinum type II, previously classified as an isolate of M peregrinum, is actually a human strain of the bovine pathogen M senegalense (3) .
M conceptionense is a recently described species of the M fortuitum complex (8) and can be differentiated from M senegalense due to its different biochemical activity and growth characteristics (Table 1) . A combination of carbohydrate utilization tests and molecular studies enable laboratories to accurately identify closely related, rapidly growing mycobacteria species (10) .
Advances in molecular identification and its recognition as a human pathogen has led to an increasing, yet limited number of cases of M senegalense infection being reported. The first human case described in 2005 was a catheter-related hematological infection in a 49-year-old woman with non-Hodgkin's lymphoma in Korea (2). In North America, other cases described to date have also occurred in patients who were immunocompromised or sustained soft tissue injury, such as surgery or trauma (3,4) , with sites of infection including bone, soft tissue and long-term intravascular catheters.
Unlike many of the previously reported cases of M senegalense, our patient was fully immunized with no history of underlying illness or immune suppression. In addition, she had no known ill contacts, had not been exposed to farm animals or livestock, and had not travelled recently. Despite the infection being located on the head, she did not have associated cervical lymphadenitis, which is the most common presentation of atypical mycobacterial infection in healthy North American children (11) .
While members of the M fortuitum complex are recognized as environmental pathogens (found in water and soil), no clear habitat for human strains of M senegalense outside of Africa has been reported. It is not clear how our patient's lacerations became infected with M senegalense, but presumably it was present in the freshwater or the fish in the broken tank. The specific number, type or origin of the fish and exact contact between the fish and child at the time of injury are not known. The water was discarded at the time that the tank shattered; therefore, testing was not possible. We were not able to identify previous reports of M senegalense associated with aquatic life forms; however, other members of the M fortuitum complex have been associated with infections in fish (12) , including aquarium fish, such as goldfish and Siamese fighting fish. Similar to the present case, in these reports, no clear source of the organism was identified. Because other closely related members of the M fortuitum complex have been associated with fish and water infections, the present case suggests that M senegalense may be found in some aquatic environments as well and, therefore, could cause infections associated with fish and freshwater sources.
Because there has only been limited previous experience with this organism, there were no specific guidelines on the types and duration of pediatric treatment to follow for this specific organism. Therefore, the treatment course was based on the limited literature pertaining to M senegalense, literature for similar mycobacterial species and clinical response. Combination antimicrobials, together with surgical debridement, were curative in the present case.
The present case is a reminder that a wide range of atypical mycobacteria, including M senegalense, may be encountered as an etiology of soft tissue infections from unusual exposures such as from a fish tank. M senegalense may be an occasional cause of human infections in otherwise healthy and immunocompromised individuals, and appears to have broad antimicrobial susceptibilities. 
